<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Following stress signals, the p53 <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor protein plays a critical role in regulation of cell proliferation, mainly through induction of <z:mpath ids='MPATH_73'>growth arrest</z:mpath> or <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="1" pm="."><plain>Therefore, this protein needs to be strictly regulated and numerous studies have shown that the MDM2 protein is an essential element for p53 regulation in <z:mpath ids='MPATH_458'>normal</z:mpath> cells and, most importantly, that overexpression of MDM2 is responsible for p53 inactivation in various types of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>A previous study showed that this is the case in some Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) cell lines, where enhanced translation of mdm2 <z:chebi fb="5" ids="33699">messenger RNA</z:chebi> results in overexpression of the protein that complexes and inactivates <z:mp ids='MP_0002169'>wild-type</z:mp> p53 </plain></SENT>
<SENT sid="3" pm="."><plain>To further investigate the role of the p53/MDM2 complex in these <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cells, as well as in other lymphoid cells that do not overexpress MDM2, this study used antisense oligodeoxynucleotides directed either against mdm2 or against p53 </plain></SENT>
<SENT sid="4" pm="."><plain>Results show that the mdm2 antisense oligodeoxynucleotide induces <z:mpath ids='MPATH_3'>apoptosis</z:mpath> of cells that express a high or low level of MDM2 protein, only if they contain <z:mp ids='MP_0002169'>wild-type</z:mp> p53 </plain></SENT>
<SENT sid="5" pm="."><plain>Moreover, <z:mpath ids='MPATH_3'>apoptosis</z:mpath> is independent of the accumulation of p53 following mdm2 antisense treatment </plain></SENT>
<SENT sid="6" pm="."><plain>Finally, the p53 antisense oligodeoxynucleotide, which inhibits the expression of <z:mp ids='MP_0002169'>wild-type</z:mp> p53, also induces a decrease of the MDM2 level in cells, whether or not they overexpress this protein, and causes <z:mpath ids='MPATH_3'>apoptosis</z:mpath> of these cells </plain></SENT>
<SENT sid="7" pm="."><plain>These results indicate that decreasing the MDM2 protein level by directly or indirectly targeting its biosynthesis is a potent tool for the induction of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
</text></document>